Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia

Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease

(2017) Leonel E. Rojo et al.   JOURNAL OF ALZHEIMERS DISEASE

Risk factors for dementia diagnosis in German primary care practices

(2016) Anke Booker et al.   INTERNATIONAL PSYCHOGERIATRICS

Do Proton Pump Inhibitors Increase the Risk of Dementia?

(2016) Lewis H. Kuller   JAMA Neurology

Association of Proton Pump Inhibitors With Risk of Dementia

(2016) Willy Gomm et al.   JAMA Neurology

Trends in Prescription Drug Use Among Adults in the United States From 1999-2012

(2015) Elizabeth D. Kantor et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of dementia in elderly patients with the use of proton pump inhibitors

(2014) Britta Haenisch et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12Deficiency

(2013) Jameson R. Lam et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production

(2013) Nahuai Badiola et al.   PLoS One

Long-term anticholinergic use and the aging brain

(2012) Xueya Cai et al.   Alzheimers & Dementia

Finding Dementia in Primary Care: The Results of a Clinical Demonstration Project

(2012) John Riley McCarten et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Histamine-2 Receptor Antagonist Use and Incident Dementia in an Older Cohort

(2011) Shelly L. Gray et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Missed and Delayed Diagnosis of Dementia in Primary Care

(2010) Andrea Bradford et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

The Alzheimerʼs Disease Centersʼ Uniform Data Set (UDS)

(2009) Sandra Weintraub et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS